v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 3,616 $ 1,272
Vendor advances, net 2,379 2,859
Prepaid expenses and other current assets 55 38
Total Current Assets 6,050 4,169
Deferred offering costs 1,705 1,377
Intangible assets, net 182 222
Total Other Assets 1,887 1,599
TOTAL ASSETS 7,937 5,768
Current Liabilities    
Accounts payable and accrued expenses 805 992
Total Current Liabilities 805 992
Commitments and contingencies
Shareholders’ Equity    
Preferred stock, par value $0.001, 20,000,000 shares authorized; no shares issued and outstanding, respectively;
Common stock, par value $0.001, 100,000,000 shares authorized; 15,825,118 and 13,736,597 shares issued and outstanding, respectively; 16 14
Common stock to be issued, 551,000 shares outstanding at March 31, 2025 484
Additional paid-in capital 16,709 13,577
Accumulated deficit (10,077) (8,815)
Total Shareholders’ Equity 7,132 4,776
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 7,937 $ 5,768